Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Signal-detected drugs for “Decreased Appetite” categorized by therapeutic categoryTherapeutic categoryNumber of drugsDrug nameTotalreportsOther hormone preparations (including antihormone preparations)6Dulaglutide (genetical recombination), tirzepatide, semaglutide (genetical recombination), osilodrostat phosphate, liraglutide (genetical recombination), mitotane138Anti-virus agents5Nirmatrelvir & ritonavir, ribavirin, amenamevir, glecaprevir hydrate & pibrentasvir, molnupiravir507Antiepileptics5Stiripentol, fenfluramine hydrochloride, rufinamide, topiramate, clobazam95Other biological preparations4Teceleukin (genetical recombination), interferon alfa (BALL-1), peginterferon alfa-2b (genetical recombination), interferon alpha (NAMALWA),385Agents affecting metabolism, n.e.c.4Pirfenidone, adalimumab (genetical resombination), nintedanib ethanesulfonate, anamorelin hydrochloride153Other agents affecting central nervous system4Riluzole, donepezil hydrochloride, memantine hydrochloride, rivastigmine146Opium alkaloids preparations3Morphine sulfate hydrate, hydromorphone hydrochloride, oxycodone hydrochloride hydrate92Antipyretics, analgesics and anti-inflammatory agents3Sulpiride hydrate & aminopropylone, tramadol hydrochloride, buprenorphine61Anti-tuberculous agents3Aluminoparaaminosalicylate calcium hydrate, ethionamide, delamanid27Antidotes2Calcium folinate, calcium levofolinate472Thyroid and para-thyroid hormone preparations1Teriparatide (genetical recombination)34Cardiotonics1Digoxin23Antidiabetic agents1Imeglimin hydrochloride21Purgatives and clysters1Lubiprostone18Antibiotic preparations acting mainly on acid-fast bacteria1Rifabutin17Other agents affecting digestive organs1Palonosetron hydrochloride12Antidiarrheals, intestinal regulators1Loperamide hydrochloride10Mineral preparations1Sodium ferrous citrate10Calcium compounds and preparations1Precipitated calcium carbonate & cholecalciferol & magnesium carbonate9Chinese meticines1Goshajinkigan7Antiparkinsonism agents1Levodopa & carbidopa hydrate & entacapone7Hypnotics and sedatives, antianxietics1Potassium bromide5Other cardiovascular agents1Ifenprodil tartrate5Psychotropic agents1Lisdexamfetamine mesilate4Diuretics1Acetazolamide sodium3Total542261
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Analysis of drug-induced adverse reactions affecting appetite and taste using the Japanese Adverse Drug Event Report Database
Study design awaiting verification · BMC Research Notes · 2026
Original publication title
Analysis of drug-induced adverse reactions affecting appetite and taste using the Japanese Adverse Drug Event Report Database
© The Author(s) 2026
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Pharmacotherapy is a potential risk factor for undernutrition; however, the association between individual drugs and nutrition-related adverse reactions remains unknown. We aimed to explore drugs affecting appetite and taste using the Japanese Adverse Drug Event Report (JADER) database.
Source: ObjectiveAbstract: What methods does the paper describe?
JADER reports (April 2004: January 2025) were analyzed for drug safety signals across seven Preferred Terms (PTs): “Appetite disorder,” “Decreased appetite,” “Abnormal loss of weight,” “Ageusia,” “Dysgeusia,” “Hypogeusia,” and “Taste disorder.” Signal detected drugs were classified by therapeutic category, and their package insert information was reviewed.
Source: MethodsAbstract: Results
Among 20,638 nutrition-related adverse reaction reports, signals were detected for 54, 14, 24, and 13 drugs for “Decreased appetite,” “Ageusia,” “Dysgeusia,” and “Taste disorder”, respectively. No signals were detected for the other three PTs. Regarding therapeutic category, other hormone preparations were common for “Decreased appetite,” while anti-viral agents were common for “Dysgeusia” and “Taste disorder.” Of these, five and 15 drugs lacked descriptions in the package inserts regarding decreased appetite and taste-related adverse reactions, respectively.
Source: ResultsAbstract: Conclusions
This study clarified drugs that may affect appetite and taste, providing a focused list for early detection. These findings may enhance pharmacovigilance practices and inform clinical approaches for managing drug-induced nutritional concerns.
Source: ConclusionsAuthors’ abstract
Objective
Pharmacotherapy is a potential risk factor for undernutrition; however, the association between individual drugs and nutrition-related adverse reactions remains unknown. We aimed to explore drugs affecting appetite and taste using the Japanese Adverse Drug Event Report (JADER) database.
Methods
JADER reports (April 2004: January 2025) were analyzed for drug safety signals across seven Preferred Terms (PTs): “Appetite disorder,” “Decreased appetite,” “Abnormal loss of weight,” “Ageusia,” “Dysgeusia,” “Hypogeusia,” and “Taste disorder.” Signal detected drugs were classified by therapeutic category, and their package insert information was reviewed.
Results
Among 20,638 nutrition-related adverse reaction reports, signals were detected for 54, 14, 24, and 13 drugs for “Decreased appetite,” “Ageusia,” “Dysgeusia,” and “Taste disorder”, respectively. No signals were detected for the other three PTs. Regarding therapeutic category, other hormone preparations were common for “Decreased appetite,” while anti-viral agents were common for “Dysgeusia” and “Taste disorder.” Of these, five and 15 drugs lacked descriptions in the package inserts regarding decreased appetite and taste-related adverse reactions, respectively.
Conclusions
This study clarified drugs that may affect appetite and taste, providing a focused list for early detection. These findings may enhance pharmacovigilance practices and inform clinical approaches for managing drug-induced nutritional concerns.
Supplementary Information
The online version contains supplementary material available at 10.1186/s13104-026-07734-5.
Publication and source details
Original title: Analysis of drug-induced adverse reactions affecting appetite and taste using the Japanese Adverse Drug Event Report Database
Mari Maese; Shingo Kondo; Yuka Sakatsume; Makoto Takagi; Yuta Yokoyama; Hiroki Iwata; Noriko Kobayashi; Katsunori Yamaura
BMC Research Notes · 2026
© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.JST SPRINGJPMJSP2123Maese Mari Keio University Doctorate Student Grant-in-Aid Program from Ushioda Memorial FundRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:58:48.159942+00:00
DOI: 10.1186/s13104-026-07734-5 · PMC13032343